CXCL10-based diagnosis and treatment of respiratory illnesses
US7332294B2 · kind B2 · utility
4Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 17, 2004 |
| Grant date | Feb 19, 2008 |
| Priority date | — |
| Expiry date | Jun 18, 2025 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/56983
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Elevated blood levels of the chemokine CXCL10 polypeptide are associated with respiratory illnesses (e.g. SARS, influenza and community-acquired pneumonia) and are useful in diagnosis of patients. Methods are provided for diagnosis and treatment of patients suffering from respiratory illnesses. Methods are provided for identifying inhibitors of the CXCL10:CXCR3 axis, for use in treating patients suffering from respiratory illnesses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.